These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 22105726)
1. Insulin resistance and metabolic syndrome: is Helicobacter pylori criminal? Eshraghian A; Eshraghian H; Ranjbar Omrani G Minerva Gastroenterol Dietol; 2011 Dec; 57(4):379-85. PubMed ID: 22105726 [TBL] [Abstract][Full Text] [Related]
2. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586 [TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Gunji T; Matsuhashi N; Sato H; Fujibayashi K; Okumura M; Sasabe N; Urabe A Am J Gastroenterol; 2008 Dec; 103(12):3005-10. PubMed ID: 19086952 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Gunji T; Matsuhashi N; Sato H; Fujibayashi K; Okumura M; Sasabe N; Urabe A Helicobacter; 2009 Oct; 14(5):144-50. PubMed ID: 19751440 [TBL] [Abstract][Full Text] [Related]
6. Relationship between Helicobacter pylori infection and metabolic syndrome. Işıktaş Sayılar E; Çelik B; Dumlu Ş Turk J Gastroenterol; 2015 Nov; 26(6):468-73. PubMed ID: 26510087 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
9. [Relation between Helicobacter pylori infection and ischemic heart disease]. Konstacký M Cas Lek Cesk; 1998 Aug; 137(16):483-5. PubMed ID: 9748749 [TBL] [Abstract][Full Text] [Related]
10. H. pylori infection and insulin resistance: the other side of the coin. Eshraghian A Minerva Gastroenterol Dietol; 2012 Jun; 58(2):179-80. PubMed ID: 22643599 [No Abstract] [Full Text] [Related]
11. Helicobacter pylori and metabolic syndrome. Koklu H; Koklu S; Cinar H Turk J Gastroenterol; 2016 Mar; 27(2):201. PubMed ID: 26853791 [No Abstract] [Full Text] [Related]
12. Novel Advances in the Association Between Helicobacter pylori Infection, Metabolic Syndrome, and Related Morbidity. Polyzos SA; Kountouras J Helicobacter; 2015 Dec; 20(6):405-9. PubMed ID: 25854149 [No Abstract] [Full Text] [Related]
13. Helicobacter pylori: from the stomach to the heart. Pellicano R; Broutet N; Ponzetto A; Mégraud F Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1335-7. PubMed ID: 10563551 [TBL] [Abstract][Full Text] [Related]
14. [New aspects of Helicobacter pylori infection: Association with metabolic disturbances]. German SV; Bobrovnitsky IP Ter Arkh; 2017; 89(10):102-107. PubMed ID: 29171479 [TBL] [Abstract][Full Text] [Related]
15. Type B insulin resistance syndrome with Scleroderma successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection: a case report. Yang GQ; Li YJ; Dou JT; Wang BA; Lu JM; Mu YM BMC Endocr Disord; 2016 May; 16(1):20. PubMed ID: 27142369 [TBL] [Abstract][Full Text] [Related]